Brand : Celltrion

About Company

A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.

Website : https://www.celltrion.com/en-us/home/index
Youtube : https://www.youtube.com/channel/UCBw_NJS0IYxB2JslVg2JRnA
Facebook : https://www.facebook.com/CelltrionDream

Business

Biosimilar, Small Molecules, New Medicines

R&D

Biosimilar
Therapeutic Agents Against Cancer, Targeted therapy, Therapeutic Agents Against Autoimmune Diseases

Novel Therapeutic Agents
New Antibody Drugs, Fusion Technology, Vaccines

IMD&Generic
Novel Tech. Platform, New Business Models, Unmet Medical Needs, First Follower strategy

Product

Bio pharmaceutical

Generic pharmaceutical

Test Kits